We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLAS
3601
DELISTED
Class Acceleration Corp.
CLAS
$3.57M ﹤0.01%
368,046
+230,534
+168% +$2.24M
M icon
3602
CALL
Macy's
M
$6.71B
$3.56M ﹤0.01%
+187,500
New +$3.33M
KURA icon
3603
Kura Oncology
KURA
$817M
$3.55M ﹤0.01%
170,343
-873,665
-84% -$21.7M
PBYI icon
3604
Puma Biotechnology
PBYI
$407M
$3.55M ﹤0.01%
386,560
-438,902
-53% -$4.45M
EIGR
3605
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.54M ﹤0.01%
13,853
-3,088
-18% -$771K
NBIS
3606
PUT
Nebius Group N.V.
NBIS
$55.6B
$3.54M ﹤0.01%
+50,000
New +$3.28M
IPVF
3607
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$3.53M ﹤0.01%
+364,211
New +$3.55M
EFR
3608
Eaton Vance Senior Floating-Rate Fund
EFR
$315M
$3.53M ﹤0.01%
249,392
KMI icon
3609
CALL
Kinder Morgan
KMI
$69.3B
$3.53M ﹤0.01%
193,500
MRVL icon
3610
PUT
Marvell Technology
MRVL
$189B
$3.52M ﹤0.01%
+60,300
New +$2.95M
SLCR
3611
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$3.52M ﹤0.01%
364,352
+123,090
+51% +$1.2M
AMRX icon
3612
Amneal Pharmaceuticals
AMRX
$5.89B
$3.51M ﹤0.01%
685,079
+268,175
+64% +$1.52M
AX icon
3613
Axos Financial
AX
$5.89B
$3.5M ﹤0.01%
75,402
+14,664
+24% +$685K
DHI icon
3614
PUT
D.R. Horton
DHI
$42.4B
$3.5M ﹤0.01%
38,700
-2,400
-6% -$225K
CSW
3615
CSW Industrials
CSW
$5.64B
$3.49M ﹤0.01%
29,487
+11,613
+65% +$1.48M
GEO icon
3616
PUT
The GEO Group
GEO
$4.2B
$3.49M ﹤0.01%
+489,800
New +$3.08M
CRL icon
3617
CALL
Charles River Laboratories
CRL
$12.6B
$3.48M ﹤0.01%
+9,400
New +$3.14M
VIGI icon
3618
Vanguard International Dividend Appreciation ETF
VIGI
$9.18B
$3.48M ﹤0.01%
39,740
+863
+2% +$74.5K
PMGM
3619
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$3.48M ﹤0.01%
357,563
+99,179
+38% +$968K
LHC
3620
DELISTED
Leo Holdings Corp. II
LHC
$3.48M ﹤0.01%
357,664
+12,792
+4% +$125K
CHPT icon
3621
PUT
ChargePoint
CHPT
$150M
$3.47M ﹤0.01%
5,000
+2,500
+100% +$1.32M
AFAQU
3622
DELISTED
AF Acquisition Corp Units
AFAQU
$3.46M ﹤0.01%
350,000
ANEW icon
3623
ProShares MSCI Transformational Changes ETF
ANEW
$7.99M
$3.46M ﹤0.01%
+75,000
New +$3.31M
RRD
3624
CALL
DELISTED
RR Donnelley & Sons Co.
RRD
$3.45M ﹤0.01%
+550,000
New +$3M
SITM icon
3625
SiTime
SITM
$16.3B
$3.45M ﹤0.01%
27,277
+1,907
+8% +$195K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.